Night-time surgery for #CSDH shows no worse outcomes than daytime surgery—plus, fewer severe adverse events at night. Our findings challenge the traditional preference for daytime CSDH surgery. Read more in Acta Neurochirurgica: rdcu.be/dXMQi HUS Helsingin yliopistollinen sairaala Medicine and Health, University of Helsinki Rahul Raj

After #CSDH surgery, thromboembolic events (8%) were slightly more common than hemorrhagic (6%) in patients on pre-op anticoagulation for #AF. Thromboembolic events severely worsened outcomes, emphasizing the need for prevention strategies. Acta Neurochirurgica link.springer.com/10.1007/s00701…

The RELACS protocol is out! No evidence-based guidelines exist on when to safely resume anticoagulation after #CSDH surgery in AF patients (≈20–25% of cases). RELACS compares early (5d) vs late (30d) restart to balance bleeding and thrombosis risks. 📄 rdcu.be/eQoTj

After surgery for #CSDH, 14% of patients died during ~16 months follow-up. Top causes of death: • Circulatory diseases 34% • Accidents 16% • Dementia 15% Comorbidities, especially dementia, arrhythmias and prior stroke, were predictors of mortality. rdcu.be/eSI4n

New insights on #CSDH surgery: • Higher drainage volume → ↑ reoperations • Longer drainage time → ↓ reoperations • No link with 6-month outcomes CSDH drainage management may need more personalized strategies, not one standard drain time for all. journals.lww.com/neurosurgery/f…